Published in Telemedicine Week, March 4th, 2008
"The aim of the current study was to compare the antiemetic activity of different 5-hydroxytryptamine-3 receptor antagonists with that of metoclopramide. In a randomised, double-blind study, 75 patients received the following: Group M, 10 mg metoclopramide; Group K, 40 mcg. kg(-1) granisetron; and Group Z,15 mcg. kg(-1) ondansetron intravenously (IV) diluted in 20 cc 0.9% NaCl...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Week